CLDX EBITDA Margin
Celldex Therapeutics Inc · EBITDA Margin
CLDX EBITDA Margin
Latest reported-265353.57%period ending
CLDX EBITDA Margin (-1400.00% → -265353.57%)
Annual ebitda margin
High-resolution chart · PNG
CLDX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -17,028% | |
| -2,203.5043% | |
| -2,019.9622% | |
| -4,420.874% | |
| -1,420.7697% | |
| -615.3006% | |
| -1,390.0644% | |
| -761.1973% | |
| -816.2678% | |
| -1,833.7459% | |
| -2,290.6934% | |
| -3,197.9643% | |
| -1,889.5159% | |
| -485.7168% | |
| -419.2337% | |
| 9.9694% | |
| -217.8524% | |
| -603.0863% | |
| -373.7342% | |
| -368.2409% | |
| -517.0061% | |
| -172.2728% | |
| -220.3143% | |
| -191.0542% | |
| -666.6099% | |
| -1,851.4151% | |
| -671.0954% | |
| -315.8909% | |
| -608.9917% | |
| -1,027.2727% | |
| -277.5% | |
| -124.2857% | |
| -94.4444% | |
| -62.1212% | |
| -66.2921% | |
| -37.2549% | |
| -12.844% | |
| -28.2609% | |
| -81.8182% | |
| -1,400% |